Avantor (NYSE:AVTR – Get Free Report) will announce its earnings results before the market opens on Friday, July 26th. Analysts expect the company to announce earnings of $0.24 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. The firm had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.68 billion. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business’s quarterly revenue was down 5.6% on a year-over-year basis. During the same quarter last year, the company posted $0.29 EPS. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Avantor Stock Performance
Avantor stock opened at $22.35 on Thursday. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. Avantor has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The firm’s fifty day moving average price is $22.42 and its 200-day moving average price is $23.61. The stock has a market cap of $15.18 billion, a P/E ratio of 57.31, a price-to-earnings-growth ratio of 2.16 and a beta of 1.32.
Analysts Set New Price Targets
View Our Latest Analysis on AVTR
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- What is a Dividend King?
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- Following Congress Stock Trades
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.